Postoperative prevention and treatment of complications after sinus surgery

Otolaryngologic Clinics of North America

Volumn 43, Issue 4, 2010, Pages 769-779

  Tan, Bruce K ^a   Chandra, Rakesh K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chronic rhinosinusitis; Complications; Endoscopic Sinus Surgery; Outcomes; Postsurgical

Indexed keywords

ACETYLSALICYLIC ACID; AMPHOTERICIN B; BECLOMETASONE; BUDESONIDE; CARBOXYMETHYLCELLULOSE; CORTICOSTEROID; DEXAMETHASONE; FLUTICASONE PROPIONATE; HEMOSTATIC AGENT; HYALURONIC ACID; MITOMYCIN C; MOMETASONE FUROATE; NOSE SPRAY; PLACEBO; PREDNISOLONE; PREDNISONE; PSEUDOMONIC ACID; ROXITHROMYCIN; SILASTIC; TOBRAMYCIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CROSS LINKING REAGENT; FLOSEAL MATRIX; GELATIN SPONGE; GLUCOCORTICOID; MITOMYCIN;

ANTIBIOTIC THERAPY; ARTHROSCOPIC DEBRIDEMENT; ASTHMA; CHRONIC SINUSITIS; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DEBRIDEMENT; DESENSITIZATION; DRUG DOSE REGIMEN; ENDOSCOPIC SINUS SURGERY; FRONTAL SINUS; HEMOSTASIS; HUMAN; IMMUNOPATHOLOGY; NASAL LAVAGE; NASAL SYNECHIAE; NEBULIZATION; NOSE DISEASE; NOSE POLYP; OSTIAL STENOSIS; PARANASAL SINUS BLEEDING; PARANASAL SINUS DISEASE; POLYPOSIS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIMARY PREVENTION; RECURRENT DISEASE; REVIEW; RHINOSINUSITIS; SAMSTER TRIAD; SAMTER TRIAD; STENOSIS; STENT; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TURBINATE; UNSPECIFIED SIDE EFFECT; EAR NOSE THROAT SURGERY; ENDOSCOPY; LAVAGE; PARANASAL SINUS DISEASES; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RHINITIS; SINUSITIS;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CROSS-LINKING REAGENTS; DEBRIDEMENT; ENDOSCOPY; GELATIN SPONGE, ABSORBABLE; GLUCOCORTICOIDS; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; MITOMYCIN; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; PARANASAL SINUS DISEASES; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; RECURRENCE; RHINITIS; SINUSITIS; STENTS; THERAPEUTIC IRRIGATION;

EID: 77954185241     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2010.04.004     Document Type: Review

References (63)

1. Thomas M., Yawn B.P., Price D., et al. EPOS primary care guidelines: European position paper on the primary care diagnosis and management of rhinosinusitis and nasal polyps 2007-a summary. Prim Care Respir J 2008, 17:79-89.
2. Welch K.C., Stankiewicz J.A. A contemporary review of endoscopic sinus surgery: techniques, tools, and outcomes. Laryngoscope 2009, 119:2258-2268.
3. Soler Z.M., Mace J., Smith T.L. Symptom-based presentation of chronic rhinosinusitis and symptom-specific outcomes after endoscopic sinus surgery. Am J Rhinol 2008, 22:297-301.
4. Senior B.A., Kennedy D.W., Tanabodee J., et al. Long-term results of functional endoscopic sinus surgery. Laryngoscope 1998, 108:151-157.
5. Cohen N.A., Kennedy D.W. Revision endoscopic sinus surgery. Otolaryngol Clin North Am 2006, 39:417-435. vii.
6. Kuhn F.A., Citardi M.J. Advances in postoperative care following functional endoscopic sinus surgery. Otolaryngol Clin North Am 1997, 30:479-490.
7. Tan B.K., Schleimer R.P., Kern R.C. Perspectives on the etiology of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2010, 18:21-26.
8. Valentine R., Wormald P.J., Sindwani R. Advances in absorbable biomaterials and nasal packing. Otolaryngol Clin North Am 2009, 42:813-828.
9. Orlandi R.R., Lanza D.C. Is nasal packing necessary following endoscopic sinus surgery?. Laryngoscope 2004, 114:1541-1544.
10. Bugten V., Nordgard S., Skogvoll E., et al. Effects of nonabsorbable packing in middle meatus after sinus surgery. Laryngoscope 2006, 116:83-88.
11. Lee J.Y., Lee S.W. Preventing lateral synechia formation after endoscopic sinus surgery with a silastic sheet. Arch Otolaryngol Head Neck Surg 2007, 133:776-779.
12. Gall R.M., Witterick I.J., Shargill N.S., et al. Control of bleeding in endoscopic sinus surgery: use of a novel gelatin-based hemostatic agent. J Otolaryngol 2002, 31:271-274.
13. Baumann A., Caversaccio M. Hemostasis in endoscopic sinus surgery using a specific gelatin-thrombin-based agent (FloSeal). Rhinology 2003, 41:244-249.
14. Chandra R.K., Conley D.B., Haines G.K., et al. Long-term effects of FloSeal packing after endoscopic sinus surgery. Am J Rhinol 2005, 19:240-243.
15. Chandra R.K., Conley D.B., Kern R.C. The effect of FloSeal on mucosal healing after endoscopic sinus surgery: a comparison with thrombin-soaked gelatin foam. Am J Rhinol 2003, 17:51-55.
16. Shrime M.G., Tabaee A., Hsu A.K., et al. Synechia formation after endoscopic sinus surgery and middle turbinate medialization with and without FloSeal. Am J Rhinol 2007, 21:174-179.
17. Antisdel J.L., West-Denning J.L., Sindwani R. Effect of microporous polysaccharide hemispheres (MPH) on bleeding after endoscopic sinus surgery: randomized controlled study. Otolaryngol Head Neck Surg 2009, 141:353-357.
18. Szczygielski K., Rapiejko P., Wojdas A., et al. Use of CMC foam sinus dressing in FESS. Eur Arch Otorhinolaryngol 2010, 267:537-540.
19. Wormald P.J., Boustred R.N., Le T., et al. A prospective single-blind randomized controlled study of use of hyaluronic acid nasal packs in patients after endoscopic sinus surgery. Am J Rhinol 2006, 20:7-10.
20. Bolger W.E., Kuhn F.A., Kennedy D.W. Middle turbinate stabilization after functional endoscopic sinus surgery: the controlled synechiae technique. Laryngoscope 1999, 109:1852-1853.
21. Friedman M., Schalch P. Middle turbinate medialization with bovine serum albumin tissue adhesive (BioGlue). Laryngoscope 2008, 118:335-338.
22. Moukarzel N., Nehme A., Mansour S., et al. Middle turbinate medialization technique in functional endoscopic sinus surgery. J Otolaryngol 2000, 29:144-147.
23. Thornton R.S. Middle turbinate stabilization technique in endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg 1996, 122:869-872.
24. Chung J.H., Cosenza M.J., Rahbar R., et al. Mitomycin C for the prevention of adhesion formation after endoscopic sinus surgery: a randomized, controlled study. Otolaryngol Head Neck Surg 2002, 126:468-474.
25. Anand V.K., Tabaee A., Kacker A., et al. The role of mitomycin C in preventing synechia and stenosis after endoscopic sinus surgery. Am J Rhinol 2004, 18:311-314.
26. Konstantinidis I., Tsakiropoulou E., Vital I., et al. Intra- and postoperative application of Mitomycin C in the middle meatus reduces adhesions and antrostomy stenosis after FESS. Rhinology 2008, 46:107-111.
27. Bednarski K.A., Kuhn F.A. Stents and drug-eluting stents. Otolaryngol Clin North Am 2009, 42:857-866.
28. Weber R., Mai R., Hosemann W., et al. The success of 6-month stenting in endonasal frontal sinus surgery. Ear Nose Throat J 2000, 79:930-932. , 934, 937-8 passim.
29. Orlandi R.R., Knight J. Prolonged stenting of the frontal sinus. Laryngoscope 2009, 119:190-192.
30. Bugten V., Nordgard S., Steinsvag S. The effects of debridement after endoscopic sinus surgery. Laryngoscope 2006, 116:2037-2043.
31. Lee J.Y., Byun J.Y. Relationship between the frequency of postoperative debridement and patient discomfort, healing period, surgical outcomes, and compliance after endoscopic sinus surgery. Laryngoscope 2008, 118:1868-1872.
32. Freeman S.R., Sivayoham E.S., Jepson K., et al. A preliminary randomised controlled trial evaluating the efficacy of saline douching following endoscopic sinus surgery. Clin Otolaryngol 2008, 33:462-465.
33. Pinto J.M., Elwany S., Baroody F.M., et al. Effects of saline sprays on symptoms after endoscopic sinus surgery. Am J Rhinol 2006, 20:191-196.
34. Wormald P.J., Cain T., Oates L., et al. A comparative study of three methods of nasal irrigation. Laryngoscope 2004, 114:2224-2227.
35. Unal M., Gorur K., Ozcan C. Ringer-lactate solution versus isotonic saline solution on mucociliary function after nasal septal surgery. J Laryngol Otol 2001, 115:796-797.
36. Welch K.C., Cohen M.B., Doghramji L.L., et al. Clinical correlation between irrigation bottle contamination and clinical outcomes in postfunctional endoscopic sinus surgery patients. Am J Rhinol Allergy 2009, 23:401-404.
37. Nadel D.M., Lanza D.C., Kennedy D.W. Endoscopically guided cultures in chronic sinusitis. Am J Rhinol 1998, 12:233-241.
38. Al-Shemari H., Abou-Hamad W., Libman M., et al. Bacteriology of the sinus cavities of asymptomatic individuals after endoscopic sinus surgery. J Otolaryngol 2007, 36:43-48.
39. Psaltis A.J., Weitzel E.K., Ha K.R., et al. The effect of bacterial biofilms on postsinus surgical outcomes. Am J Rhinol 2008, 22:1-6.
40. Kilty S.J., Desrosiers M.Y. Are biofilms the answer in the pathophysiology and treatment of chronic rhinosinusitis?. Immunol Allergy Clin North Am 2009, 29:645-656.
41. Wallwork B., Coman W., Mackay-Sim A., et al. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 2006, 116:189-193.
42. Moss R.B., King V.V. Management of sinusitis in cystic fibrosis by endoscopic surgery and serial antimicrobial lavage. Reduction in recurrence requiring surgery. Arch Otolaryngol Head Neck Surg 1995, 121:566-572.
43. Desrosiers M.Y., Salas-Prato M. Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: results of a controlled trial. Otolaryngol Head Neck Surg 2001, 125:265-269.
44. Uren B., Psaltis A., Wormald P.J. Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis. Laryngoscope 2008, 118:1677-1680.
45. Ponikau J.U., Sherris D.A., Weaver A., et al. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 2005, 115:125-131.
46. Ebbens F.A., Scadding G.K., Badia L., et al. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006, 118:1149-1156.
47. Weschta M., Rimek D., Formanek M., et al. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 2004, 113:1122-1128.
48. Dingsor G., Kramer J., Olsholt R., et al. Flunisolide nasal spray 0.025% in the prophylactic treatment of nasal polyposis after polypectomy. A randomized, double-blind, parallel, placebo-controlled study. Rhinology 1985, 23:49-58.
49. Hartwig S., Linden M., Laurent C., et al. Budesonide nasal spray as prophylactic treatment after polypectomy (a double-blind clinical trial). J Laryngol Otol 1988, 102:148-151.
50. Dijkstra M.D., Ebbens F.A., Poublon R.M., et al. Fluticasone propionate aqueous nasal spray does not influence the recurrence rate of chronic rhinosinusitis and nasal polyps 1 year after functional endoscopic sinus surgery. Clin Exp Allergy 2004, 34:1395-1400.
51. Rowe-Jones J.M., Medcalf M., Durham S.R., et al. Functional endoscopic sinus surgery: 5-year follow-up and results of a prospective, randomised, stratified, double-blind, placebo-controlled study of postoperative fluticasone propionate aqueous nasal spray. Rhinology 2005, 43:2-10.
52. Jorissen M., Bachert C. Effect of corticosteroids on wound healing after endoscopic sinus surgery. Rhinology 2009, 47:280-286.
53. Lavigne F., Cameron L., Renzi P.M., et al. Intrasinus administration of topical budesonide to allergic patients with chronic rhinosinusitis following surgery. Laryngoscope 2002, 112:858-864.
54. Kanowitz S.J., Batra P.S., Citardi M.J. Topical budesonide via mucosal atomization device in refractory postoperative chronic rhinosinusitis. Otolaryngol Head Neck Surg 2008, 139:131-136.
55. Citardi M.J., Kuhn F.A. Endoscopically guided frontal sinus beclomethasone instillation for refractory frontal sinus/recess mucosal edema and polyposis. Am J Rhinol 1998, 12:179-182.
56. DelGaudio J.M., Wise S.K. Topical steroid drops for the treatment of sinus ostia stenosis in the postoperative period. Am J Rhinol 2006, 20:563-567.
57. Stevenson D.D., Hankammer M.A., Mathison D.A., et al. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 1996, 98:751-758.
58. Rozsasi A., Polzehl D., Deutschle T., et al. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy 2008, 63:1228-1234.
59. Lee J.Y., Simon R.A., Stevenson D.D. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2007, 119:157-164.
60. Ulualp S.O., Sterman B.M., Toohill R.J. Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease. Ear Nose Throat J 1999, 78:604-606. , 608, 613 passim.
61. Bleier B.S., Paulson D.P., O'Malley B.W., et al. Chitosan glycerophosphate-based semirigid dexamethasone eluting biodegradable stent. Am J Rhinol Allergy 2009, 23:76-79.
62. Erickson V.R., Antunes M., Chen B., et al. The effects of retinoic acid on ciliary function of regenerated sinus mucosa. Am J Rhinol 2008, 22:334-336.
63. Cohen M., Kofonow J., Nayak J.V., et al. Biofilms in chronic rhinosinusitis: a review. Am J Rhinol Allergy 2009, 23:255-260.